In a move that could eventually make weight loss drugs cheaper and easier to access, the Food and Drug Administration Monday ...

The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide ...

Takers of GLP-1 are reportedly going on a "holiday pause" to enjoy meal centric family celebrations. Here, an MD breaks down the risks of the trend.

Weight loss drugs like Ozempic and Wegovy have seemingly taken over this year, curbing users appetites by making them feel ...

Semaglutide, the active ingredient in Ozempic and Wegovy, has been linked to a condition that can cause permanent vision loss ...

Lawyers are looking at emerging litigation over plastic pollution and video game addiction, while cases over diet drugs, ...

Tirzepatide, the active ingredient in both Mounjaro for type 2 diabetes and Zepbound for weight loss, was in short supply for ...

On today’s Big Take podcast, Bloomberg reporter Madison Muller joins host Sarah Holder to share what she’s learned about the ways telehealth can make it easier for people to get prescriptions that ...

Connecticut law requires Medicaid to cover certain weight loss drugs, but officials say it hasn't been happening due to cost ...

The rise of so-called "critical disability studies" is increasingly becoming a point of contention in discussions surrounding health, wellness, and societal norms. The latest outcry comes from Fady ...

Independence Blue Cross said starting Jan. 1 it will only be covering GLP-1 agonists — commonly sold under brand names like Wegovy and Ozempic — when prescribed for their Food and Drug Administration ...

Two later-stage trials investigating semaglutide, the drug in Ozempic, for treating Alzheimer's disease are due to complete ...